ARIDIS_LOGO.png
Aridis Provides Corporate Update
June 24, 2024 17:58 ET | Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent...
ARIDIS_LOGO.png
Aridis Pharmaceuticals Announces $2 Million Offering
August 02, 2023 08:17 ET | Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies...